Jens Schneider-Mergener
Keine laufenden Positionen mehr
Profil
Jens Schneider-Mergener is the founder of Pharvaris NV, which was founded in 2015.
He was the Chief Executive Officer at Shire Orphan Therapies GmbH.
He also served as the Chief Executive Officer at AdrenoMed AG from 2019 to 2021.
Dr. Schneider-Mergener received his undergraduate degree from the University of Bielefeld and his doctorate from Ludwig-Maximilians-Universität München.
Ehemalige bekannte Positionen von Jens Schneider-Mergener
Unternehmen | Position | Ende |
---|---|---|
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Vorstandsvorsitzender | 01.01.2021 |
PHARVARIS N.V. | Gründer | - |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Vorsitzender | - |
Ausbildung von Jens Schneider-Mergener
University of Bielefeld | Undergraduate Degree |
Ludwig-Maximilians-Universität München | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHARVARIS N.V. | Health Technology |
Private Unternehmen | 2 |
---|---|
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |